Once-daily intramuscular amikacin for outpatient treatment of lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli in children

BACKGROUND: The rise in community-acquired urinary tract infections (UTIs) with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli strains raises the question of how to treat these infections effectively in pediatric outpatients. Amikacin has shown promising in vitro activity against ES...

Descripción completa

Detalles Bibliográficos
Autores principales: Polat, Meltem, Kara, Soner Sertan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674974/
https://www.ncbi.nlm.nih.gov/pubmed/29138582
http://dx.doi.org/10.2147/IDR.S148703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674974/
https://www.ncbi.nlm.nih.gov/pubmed/29138582
http://dx.doi.org/10.2147/IDR.S148703

Ejemplares similares